Harvard Men's Health Watch

Relationship of vitamin E and prostate cancer benefits not resolved, men's newsletter says

Published in Oncology Business Week, January 29th, 2006

The U.S. Preventive Services Task Force recently recommended against routine vitamin use to prevent cancer and cardiovascular disease. The recommendation was based on a series of clinical trials that found that antioxidant supplements do not reduce the risks of these diseases.

However, just a few weeks later, results from the alpha-tocopherol, beta carotene (ATBC) cancer prevention trial showed that men with high blood levels of alpha-tocopherol (a form of vitamin E) had a lower risk of prostate cancer, reports Harvard Men's Health Watch.

"The ATBC research provides some support for vitamin E, but it's not conclusive," said Dr. Harvey Simon,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2006-01-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry